ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $33,000 | -76.3% | 1,185 | -73.1% | 0.00% | – |
Q4 2020 | $139,000 | -93.4% | 4,413 | -92.8% | 0.00% | -100.0% |
Q3 2020 | $2,120,000 | -50.2% | 60,999 | -25.8% | 0.00% | -50.0% |
Q2 2020 | $4,253,000 | +22284.2% | 82,241 | +14202.8% | 0.00% | – |
Q1 2020 | $19,000 | -91.5% | 575 | -84.7% | 0.00% | – |
Q4 2019 | $224,000 | +121.8% | 3,762 | +36.2% | 0.00% | – |
Q3 2019 | $101,000 | -19.2% | 2,762 | +3.4% | 0.00% | – |
Q2 2019 | $125,000 | +443.5% | 2,671 | +364.5% | 0.00% | – |
Q1 2019 | $23,000 | -43.9% | 575 | -36.0% | 0.00% | – |
Q4 2018 | $41,000 | +24.2% | 898 | +22.5% | 0.00% | – |
Q3 2018 | $33,000 | +13.8% | 733 | -0.7% | 0.00% | – |
Q2 2018 | $29,000 | -31.0% | 738 | +28.3% | 0.00% | – |
Q1 2018 | $42,000 | -91.6% | 575 | -92.4% | 0.00% | – |
Q4 2017 | $500,000 | +525.0% | 7,596 | +375.9% | 0.00% | – |
Q3 2017 | $80,000 | +185.7% | 1,596 | +167.8% | 0.00% | – |
Q2 2017 | $28,000 | -88.0% | 596 | -91.0% | 0.00% | – |
Q1 2017 | $233,000 | +3783.3% | 6,596 | +1006.7% | 0.00% | – |
Q4 2016 | $6,000 | -40.0% | 596 | -14.1% | 0.00% | – |
Q3 2016 | $10,000 | -95.3% | 694 | -96.8% | 0.00% | – |
Q2 2016 | $215,000 | +43.3% | 21,735 | +144.2% | 0.00% | – |
Q1 2016 | $150,000 | +4.2% | 8,901 | +36.7% | 0.00% | – |
Q4 2015 | $144,000 | +1500.0% | 6,512 | +1600.3% | 0.00% | – |
Q3 2015 | $9,000 | -55.0% | 383 | +53.2% | 0.00% | – |
Q2 2015 | $20,000 | -91.7% | 250 | -90.4% | 0.00% | – |
Q1 2015 | $241,000 | +588.6% | 2,604 | +204.9% | 0.00% | – |
Q4 2014 | $35,000 | +66.7% | 854 | 0.0% | 0.00% | – |
Q3 2014 | $21,000 | +950.0% | 854 | +676.4% | 0.00% | – |
Q2 2014 | $2,000 | – | 110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |